The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 ) | MicrobiomeTrials← Back to trialsNCT03999580
The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )
TERMINATEDPHASE3INTERVENTIONAL
Trial Details
Start: 2020-02-07Est. Completion: 2023-09-29
Enrollment target: 55 participants Locations- Stollery Children's Hospital, Edmonton, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- Children's Hospital, Winnipeg, Manitoba, Canada
- McMaster University, Hamilton, Ontario, Canada
- London Health Sciences Centre, London, Ontario, Canada
- Montreal Children's Hospital, Montreal, Quebec, Canada
- CHU Sainte-Justine, Montreal, Quebec, Canada
Other microbiome trials you might be interested in
Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative
Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…
Multiple LocationsEst. completion Oct 31, 2032
Inflammatory Bowel Disease
This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…
Suqian, ChinaCompleted Mar 30, 2026
Phase 4
Recruiting
This is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 pa…
Miami, United StatesEst. completion Sep 1, 2027